Answers are grounded in this paper and cite their sources.
Drug delivery to the inner ear is a key technology for treating sensorineural hearing loss. Due to the presence of physiological barriers such as the blood-labyrinth barrier and the round window membrane, it is difficult for drugs to effectively reach target tissues in the inner ear. Mouse models, with their well-defined genetic backgrounds and short breeding cycles, have become the primary tools for research on inner ear drug delivery. This article reviews the main obstacles and delivery strategies of drug delivery in the inner ear of mice, focusing on the research progress of intratympanic injection, direct cochlear injection, nanocarriers, hydrogels and gene delivery vehicles. The advantages and disadvantages of each method and the corresponding precise delivery strategies for different deafness types are analyzed, and future directions in this field are discussed.
No takes yet. Share an insight, caveat, or question.
Yanru Li (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: